Abstract
Valentina Greco, Alessandro Giuffrida, Marcello Locatelli, Fabio Savini, Ugo de Grazia, Luigi Ciriolo, Miryam Perrucci, Halil Ibrahim Ulusoy, Cristian D'Ovidio, Antonio Maria Catena
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
Homogeneous liquid–liquid extraction as an alternative sample preparation technique for biomedical analysis
10.1002/jssc.202100452 · 2022
Novel applications of microextraction techniques focused on biological and forensic analyses
10.3390/separations9010018 · 2022
Recent trends in microextraction techniques employed in analytical and bioanalytical sample preparation
10.3390/separations4040036 · 2017
Green sample preparation of alternative biosamples in forensic toxicology
2021
Systematic strategies for degradation kinetic study of pharmaceuticals: an issue of utmost importance concerning current stability analysis practices
10.1186/s40543-022-00317-6 · 2022
Stability of analytes in biosamples - an important issue in clinical and forensic toxicology?
10.1007/s00216-007-1267-2 · 2007
Preanalytic aspects
10.4155/ebo.13.56 · 2013
Laboratory sample stability. Is it possible to define a consensus stability function? An example of five blood magnitudes
10.1515/cclm-2017-1189 · 2018
A sustainable approach for the stability study of psychotropic substances using vitreous humor and liver as alternative matrices
10.1007/s00216-022-04064-w · 2022
Cannabinoid stability in antemortem and postmortem blood
10.1093/jat/bkz073 · 2020
An investigation of the stability of emerging new psychoactive substances
10.1002/dta.1576 · 2014
Analytical methods for herbal products containing synthetic cannabinoids: a review
2022
A review of synthetic cathinones emerging in recent years (2019–2022)
10.1007/s11419-022-00639-5 · 2023
Identification of AD-18, 5F-MDA-19, and pentyl MDA-19 in seized materials after the class-wide ban of synthetic cannabinoids in China
10.1002/dta.3185 · 2022
Structure elucidation of the novel synthetic cannabinoid Cumyl-Tosyl-Indazole-3-Carboxamide (Cumyl-TsINACA) found in illicit products in Germany
10.1002/dta.3261 · 2022
Chemical classification of new psychoactive substances (NPS)
10.1016/j.microc.2020.105877 · 2021
The role of the pathology department in the preanalytical phase of molecular analyses
10.2147/cmar.s150851 · 2018
Effect of serum sample storage temperature on metabolomic and proteomic biomarkers
10.1038/s41598-022-08429-0 · 2022
A chemical rationale of drug stability and degradation- an insightful approach
10.18231/j.ijcaap.2022.019 · 2022
Chemical stability of pharmaceutical organic compounds
10.34297/ajbsr.2019.06.000984 · 2019
Comparative chemical and biological hydrolytic stability of homologous esters and isosteres
10.1080/14756366.2022.2027933 · 2022
Investigating the stability of six phenolic TMZ ester analogues, incubated in the presence of porcine liver esterase and monitored by HPLC
10.3390/molecules27092958 · 2022
Stability studies in biological fluids during post-analysis custody. Opiate compounds derived from heroin consumption
10.1016/j.forsciint.2019.02.016 · 2019
Kinetics of CBD, Δ9-THC degradation and cannabinol formation in Cannabis Resin at various temperature and pH conditions
10.1089/can.2021.0004 · 2022
Phenols in pharmaceuticals: analysis of a recurring motif
10.1021/acs.jmedchem.2c00223 · 2022
Plasma pharmacokinetics and tissue distribution of doxorubicin in rats following treatment with astragali radix
10.3390/ph15091104 · 2022
Interspecies prediction of pharmacokinetics and tissue distribution of doxorubicin by physiologically-based pharmacokinetic modeling
10.1002/bdd.2229 · 2020
New insights into the activities and toxicities of the old anticancer drug doxorubicin
10.1111/febs.15583 · 2021
Four new degradation products of doxorubicin: an application of forced
10.1016/j.jpha.2015.05.003 · 2015
Minimization of the preanalytical error in plasma samples for pharmacokinetic analyses and therapeutic drug monitoring–using doxorubicin as an example
10.1097/ftd.0b013e31823aa8ab · 2011
Bioanalysis of doxorubicin aglycone metabolites in human plasma samples–implications for doxorubicin drug monitoring
10.1038/s41598-020-75662-w · 2020
Chemical stability study of H1 antihistaminic drugs from the first and the second generations, diphenhydramine, azelastine and bepotastine, in pure APIs and in the presence of two excipients, citric acid and polyvinyl alcohol
10.3390/molecules27238322 · 2022
Practical and science-based strategy for establishing acceptable intakes for drug product N-Nitrosamine impurities
10.1021/acs.chemrestox.1c00369 · 2022
The importance of amine-degrading enzymes on the biogenic amine degradation in fermented foods: a review
10.1016/j.procbio.2020.09.012 · 2020
A review of pretreatment and analytical methods of biogenic amines in food and biological samples since 2010"
2019
Cathinone stability in authentic urine specimens
10.1016/j.forsciint.2018.02.016 · 2018
Biosensors for biogenic amines: a review
2021
Extended stability evaluation of selected cathinones
10.3389/fchem.2020.597726 · 2020
Pharmacokinetic study of ephedrine and pseudoephedrine after oral administration of Ojeok-San by validated LC-MS/MS method in human plasma
10.3390/molecules26226991 · 2021
Physicochemical and microbiological stability of two oral solutions of methadone hydrochloride 10mg/mL
10.3390/molecules27092812 · 2022
Oxidative metabolism of the anti-cancer agent mitoxantrone by horseradish, lacto-and lignin peroxidase
10.1016/j.biochi.2010.09.015 · doi-reference
Cocaine: an updated overview on chemistry, detection, biokinetics, and pharmacotoxicological aspects including abuse pattern
10.3390/toxins14040278 · doi-reference
Stabilization of clinical samples collected for quantitative bioanalysis-a reflection from the European Bioanalysis Forum
10.4155/bio.14.290 · doi-reference
Thermal inactivation of enzymes and pathogens in biosamples for MS analysis
10.4155/bio.15.122 · doi-reference
Sample pre-treatment procedures for the omics analysis of human gut microbiota: turning points, tips and tricks for gene sequencing and metabolomics
10.1016/j.jpba.2020.113592 · doi-reference
Stabilization of tissue specimens for pathological examination and biomedical research
10.1089/bio.2012.0031 · doi-reference
Could biological tissue preservation methods change chemical elements proportion measured by energy dispersive X-ray spectroscopy?
10.1007/s12011-019-01909-x · doi-reference
Chemical approaches to cryopreservation
10.1038/s41570-022-00407-4 · doi-reference
Cryopreservation of tissues by slow-freezing using an emerging zwitterionic cryoprotectant
10.1038/s41598-022-23913-3 · doi-reference
Deleterious effects of formalin-fixation and delays to fixation on RNA and miRNA-Seq profiles
10.1038/s41598-019-43282-8 · doi-reference
Accuracy of whole slide image based image analysis is adversely affected by preanalytical factors such as stained tissue slide and paraffin block age
10.1016/j.jpi.2022.100121 · doi-reference
The mutational signatures of formalin fixation on the human genome
10.1038/s41467-022-32041-5 · doi-reference
Validation of a new salt-assisted HS-GC-FID method for the determination of ethanol in vitreous humor
10.1093/jat/bkac087 · doi-reference
Ethanol determination in post-mortem samples: correlation between blood and vitreous humor concentration
10.3390/molecules25122724 · doi-reference
Frequency of postmortem ethanol formation in blood, urine and vitreous humor - improving diagnostic accuracy with the use of ethylsulphate and putrefactive alcohols
10.1016/j.forsciint.2021.111152 · doi-reference
In vitro formation of ethanol in autopsy samples containing fluoride ions
10.1007/s00414-007-0166-6 · doi-reference
A study of ethyl glucuronide in post-mortem blood as a marker of ante-mortem ingestion of alcohol
10.1016/j.forsciint.2006.02.045 · doi-reference
Significant postmortem diffusion of ethanol: a case report
10.1016/j.forsciint.2021.111046 · doi-reference
Modeling postmortem ethanol production/insights into the origin of higher alcohols
10.3390/molecules27030700 · doi-reference
Microbial degradation of forensic samples of biological origin: potential threat to human DNA typing
10.1007/s12033-017-0052-5 · doi-reference
Guidelines for collection of biological samples for clinical and forensic toxicological analysis
10.1080/20961790.2016.1271098 · doi-reference
Cross-reactive chemical sensor arrays
10.1021/cr980102w · doi-reference
Determination of cross-reactivity of contemporary cannabinoids with THC direct immunoassay (ELISA) in whole blood
10.1093/jat/bkac051 · doi-reference
Analyte sensing with unselectively binding synthetic receptors: virtues of time-resolved supramolecular assays
10.1039/d2cc04831k · doi-reference
Metabolism-mediated drug–drug interactions – Study design, data analysis, and implications for in vitro evaluations
10.1016/j.medidd.2022.100121 · doi-reference
Effect of collection, transport, processing and storage of blood specimens on the activity of lysosomal enzymes in plasma and leukocytes
10.1590/s0100-879x2000000900003 · doi-reference
Reactions and enzymes in the metabolism of drugs and other xenobiotics
10.1016/j.drudis.2012.01.017 · doi-reference
Current developments of bioanalytical sample preparation techniques in pharmaceuticals
10.1016/j.jpha.2022.03.001 · doi-reference
An overview of sample preparation in forensic toxicology
10.1002/wfs2.1436 · doi-reference
Dual effects of NV-CoV-2 biomimetic polymer: an antiviral regimen against COVID-19
10.1371/journal.pone.0278963 · doi-reference
Identification and characterization of degradation products of Remdesivir using liquid chromatography/mass spectrometry
10.1039/d1nj00160d · doi-reference
Highly sensitive and selective sensing probe for determination of anti-Covid-19 Remdesvir: application to pharmaceutical dosage form and biological fluids
10.1149/1945-7111/ac53ca · doi-reference
Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient
10.1515/cclm-2020-0612 · doi-reference
Rapid determination of remdesivir (SARS-CoV-2 drug) in human plasma for therapeutic drug monitoring in COVID-19-Patients
10.1016/j.procbio.2020.12.014 · doi-reference
Pharmacokinetics and tissue distribution of remdesivir and its metabolites nucleotide monophosphate, nucleotide triphosphate, and nucleoside in mice
10.1038/s41401-020-00537-9 · doi-reference
Efficiency of bis-amidate phosphonate prodrugs
10.1016/j.bmcl.2022.128724 · doi-reference
Metabolic efficacy of phosphate prodrugs and the Remdesivir paradigm
10.1021/acsptsci.0c00076 · doi-reference
Development and clinical application of phosphorus-containing drugs
10.1016/j.medidd.2020.100063 · doi-reference
Pharmacokinetic properties of a novel formulation of S-adenosyl-l-methionine phytate
10.1007/s00726-021-03076-7 · doi-reference
Determination of S-Adenosylmethionine and S-Adenosylhomocysteine by LC-MS/MS and evaluation of their stability in mice tissues
10.1016/j.jchromb.2009.05.039 · doi-reference